Category: Adverse Drug Events

Opioid Stigma Resources Collection

Compiled by IPRO HQIC

The following are websites where you can resources related to Opioid Stigma:

Articles:

  1. CDC. “Patients’ Frequently Asked Questions | CDC’s Response to the Opioid Overdose Epidemic | CDC.” Www.cdc.gov, 19 Oct. 2021, www.cdc.gov/opioids/patients/faq.html. Spanish Language version available here.
  2. CDC. “Stigma Reduction.” Www.cdc.gov, 25 July 2023, www.cdc.gov/stopoverdose/stigma/index.html. Accessed 10 Oct. 2023.
  3. IPRO HQIC. “Naloxone Saves Lives – HQIC Resource Library.” IPRO HQIC Resource Library, 20 Sept. 2022, hqic-library.ipro.org/2022/09/20/naloxone-saves-lives/. Accessed 10 Oct. 2023. Spanish language version available here.
  4. IPRO HQIC. “People Matter, Words Matter – IPRO QIN-QIO Resource Library.” IPRO HQIC Resource Library, 28 July 2023, qi-library.ipro.org/2023/07/28/people-matter-words-matter/. Accessed 10 Oct. 2023.
  5. Where Opioid Use Disorder Stigma Comes From and How to Prevent It Opioid Use Disorder Stigma: Causes, Impact, Prevention (healthline.com) 
  6. 4 Factors That Add to Stigma Surrounding Opioid Use Disorder 4 factors that add to stigma surrounding opioid-use disorder | American Medical Association (ama-assn.org) 
  7. Stop Overdose: Stigma Reduction Stigma Reduction (cdc.gov) (PDF flyer REDUCING STIGMA (cdc.gov)) 
  8. The stigma that undermines care The stigma that undermines care (apa.org) 
  9. Stigma: Overcoming a Barrier to Pain Treatment and Addiction Recovery Stigma: Overcoming a Barrier to Pain Treatment and Addiction Recovery | NIH HEAL Initiative 
  10. Substance Use Disorder Stigma: What it is and How You Can Prevent it Substance Use Disorder Stigma: What it is and How You Can Prevent it | USU 
  11. Punishing Drug Use Heightens the Stigma of Addiction Punishing Drug Use Heightens the Stigma of Addiction | National Institute on Drug Abuse (NIDA) (nih.gov) 
  12. Medical Stigma and Patients with Substance Abuse Disorder Medical Stigma and Patients with Substance Abuse Disorders | Psychology Today 
  13. Panel Discussion: Stigma Around Opioid Use Disorder Presents Challenges to Treatment Stigma Around Opioid Use Disorder Presents Challenges to Treatment | The Pew Charitable Trusts (pewtrusts.org) 
  14. Stigma of opioids a hurdle to solving crisis Stigma of opioids keeps users from seeking help, taints views of medical professionals – Harvard Gazette 
  15. Why Opioid Addiction Should Be Viewed-And Treated-Like a Chronic Disease Opioid Use Disorder: Managing Stigma & Treatment | The Well by Northwell 

Blogs Posts:

  1. Part 1: Guiding Principles for Addressing the Stigma on Opioid Addiction Guiding Principles for Addressing the Stigma on Opioid Addiction | Bloomberg American Health Initiative (jhu.edu) 
  2. Part 2: A Roadmap to Reduce Stigma on Opioid Addiction A Roadmap to Reduce Stigma on Opioid Addiction | Bloomberg American Health Initiative (jhu.edu) 

Journal Articles:

  1. Confronting the Stigma of Opioid Use Disorder- and Its Treatment Confronting the Stigma of Opioid Use Disorder—and Its Treatment | Substance Use and Addiction Medicine | JAMA | JAMA Network 
  2. Social Stigma Toward Persons with Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health-Oriented Policies Social Stigma Toward Persons With Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health–Oriented Policies | Psychiatric Services (psychiatryonline.org) 
  3. Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination – ScienceDirect 
  4. The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy – PubMed (nih.gov) 
  5. Stigma, discrimination and the health of illicit drug users Stigma, discrimination and the health of illicit drug users – PubMed (nih.gov) 
  6. The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder – ScienceDirect 
  7. Addressing Bias and Stigma in the Language We Use With Persons With Opioid Use Disorder: A Narrative Review Addressing Bias and Stigma in the Language We Use With Persons With Opioid Use Disorder: A Narrative Review – PubMed (nih.gov) 
  8. Opioid use-related stigma and healthcare decision-making Opioid use-related stigma and health care decision-making – PubMed (nih.gov) 

Buprenorphine for Pain: A Transition Guide from Full Agonist Opioid Prescriptions

Prepared by IPRO

Buprenorphine for Pain: A Transition Guide from Full Agonist Opioid Prescriptions is a tool intended to aid clinicians in switching patients off of full opioid agonists to buprenorphine, a partial mixed opioid agonist for pain management.

The information presented in this document should not be considered medical advice and is not a substitute for individualized patient or client care and treatment decisions.

March 21, 2023 Joint HQIC LAN – Acute Pain Alternatives: The Impact of Avoiding Opioids on Hospital Delirium

Prepared by IPRO

Join us for this special presentation featuring real-world strategies for preventing hospital delirium! Delirium affects as many as 50% of hospitalized patients over the age of 65. Furthermore, delirium accounts for increased length of stay, hospital readmissions, emergency department visits and institutionalization of older adults. Delirium is often precipitated by opioid use for pain management. Don’t miss this discussion on alternatives, using an example of a successful hospital project. These initiatives will inspire you to take on delirium prevention at your facility!

Slides

Recording

Opioid and Pain Management Best Practices: Strategies for Success: Self – Assessment

Prepared by IPRO QIN-QIO, Centers for Medicare & Medicaid Services Quality Improvement & Innovation Group

Use with Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain document and the Opioid and Pain Management Best Practice Aggregate Results Dashboard.

IPRO HQIC presents: The Impact of Meaningful Medication Reconciliation on ADEs, January 13, 2022

This material was prepared by The Bizzell Group (Bizzell), the Data Validation and Administrative (DVA) contractor, under contract with
the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS).

Hospital leaders from across the country attend the HQIC Community of Practice Call. The small, rural and critical access voice was amplified through sharing of barriers and best practices alike. Furthermore, subject matter experts shared their perspectives and their favorite resources. This resource contains a link to the Januray 13, 2021 video, presentation slides, and tools documentation.

HQIC Antibiotic Stewardship Workgroup: Penicillin Allergy Module

Developed by the Network of Quality Improvement and Innovation Contractors for the Centers of Medicare and Medicaid Services Quality Improvement and Innovation Group – QIN/QIO HQIC

This resource contains two video conversations on how to develop and maintain a successful penicillin allergy program, and how to initiate and sustain an antibiotic allergy clarification program. Additional resources include CDC fact sheet, allergy poster, and Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals documentation.

Patient Safety & Behavioral Health: Antipsychotic Medication Adverse Drug Events (ADE’s)

This material was prepared by Alliant Quality, and adapted by the IPRO QIN-QIO, a collaboration of Healthcentric Advisors, Qlarant and IPRO, serving as the Medicare Quality Innovation Network-Quality Improvement Organization.

This resource discusses the common effects of antipsychotic ADE’s, and provides links to other resources and interventions that support the prevention of adverse events. Adverse drug events cause approximately 1.3 million emergency department visits each year. About 350,000 patients each year need to be hospitalized for further treatment after emergency visits for adverse drug events. People typically take more medicines as they age, and the risk of adverse events may increase as more people take more medicines.

National Healthcare Safety Network (NHSN)Patient Safety Analysis Resource

Centers for Disease Control and Prevention

The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.